Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Phaarmasia Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Phaarmasia Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Phaarmasia Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Phaarmasia Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Phaarmasia Ltd. - Informational Mail: Correction Of Clerical Error In Board Meeting Outcome Dated 14.02.2025.
Key fundamentals
Evaluate the intrinsic value of Phaarmasia Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 10.2983 | 10.8161 | 12.0882 | 13.7029 | 13.4586 |
| Liabilities | 10.2983 | 10.8161 | 12.0882 | 13.7029 | 13.4586 |
| Equity | 6.827 | 6.827 | 6.8269 | 6.8269 | 6.8269 |
| Gross Profit | -0.8196 | -1.5435 | -1.735 | -0.0619 | 0.8187 |
| Net Profit | -0.5182 | -1.2592 | -1.5471 | 0.3119 | 0.5397 |
| Cash From Operating Activities | 0.1072 | 0.6499 | -0.1674 | 0.2499 | 0.08 |
| NPM(%) | -1.69 | -4.58 | -8.98 | 1.56 | 2.2 |
| Revenue | 30.5933 | 27.4895 | 17.2157 | 19.8952 | 24.4536 |
| Expenses | 31.4129 | 29.033 | 18.9508 | 19.9571 | 23.6349 |
| ROE(%) | -8.55 | -20.78 | -25.54 | 5.15 | 8.91 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Phaarmasia Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 810.05 | -1.12 | 26.88 | 17.04 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 74.39 | 0.39 | 308.58 | 62.08 | 14.01 | 0.68 |
| Bharat Immunological and Biologicals Corporation Ltd | 25.66 | -5.45 | 0.00 | 128.89 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 698.00 | -1.87 | 0.00 | 58.53 | -687.11 | 0.00 |
Company Info
N.D Metal Industries Ltd. is a flag ship company of N.D. Group, is engaged in Import of Non-Ferrous Metals since last 25 years and having its manufacturing unit in Daman (Union Territory) and the Company is having its sales offices in Delhi & U.P. 2008 -Mr. Ch. Sreenivas has been appointed as a additional Director of the company. 2009 -Mr. P Vijaya Saradhi and Mr. Vinay Ramakant Sapte were appointed as additional Directors of the Company. 2014 -Mr. Maneesh R. Sapte has been appointed as a Managing Director of the Company.
N.D Metal Industries Ltd. is a flag ship company of N.D. Group, is engaged in Import of Non-Ferrous Metals since last 25 years and having its manufacturing unit in Daman (Union Territory) and the Company is having its sales offices in Delhi & U.P. 2008 -Mr. Ch. Sreenivas has been appointed as a additional Director of the company. 2009 -Mr. P Vijaya Saradhi and Mr. Vinay Ramakant Sapte were appointed as additional Directors of the Company. 2014 -Mr. Maneesh R. Sapte has been appointed as a Managing Director of the Company.
Read More
Parent Organisation
Phaarmasia Ltd.
Founded
06/02/1981
Managing Director
NSE Symbol
FAQ
The current price of Phaarmasia Ltd is
The 52-week high for Phaarmasia Ltd is
The market capitalization of Phaarmasia Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Phaarmasia Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Phaarmasia Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Phaarmasia Ltd shares.
The CEO of Phaarmasia Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
